By Mill Chart
Last update:
TG Therapeutics Inc (NASDAQ:TGTX) is a biotechnology company focused on developing treatments for B-cell malignancies and autoimmune diseases. The stock has shown strong technical and fundamental characteristics that align with Mark Minervini’s Trend Template, a method designed to identify high-potential stocks in strong uptrends.
Mark Minervini’s strategy emphasizes stocks with strong price momentum, upward-trending moving averages, and high relative strength. TGTX meets several key criteria:
View the full technical analysis report for TGTX here.
TG Therapeutics Inc (NASDAQ:TGTX) exhibits strong technical and fundamental traits that align with Minervini’s criteria for high-momentum stocks. While the setup is not yet ideal for immediate entry due to recent volatility, the stock remains a compelling candidate for further analysis.
[Find more high-growth momentum stocks using the Minervini Trend Template here.](https://www.chartmill.com/stock/stock-screener?sid=718&f=sm50v_a_sm150v,sm50v_a_sm200v,sl_crs_70_X,sm200v_r,sm150v_a_sm200v,v1_50b100,cu_a_sm50v,cu_a_sm150v,cu_a_sm200v,sl_ratingHgm_6_X,exch_us&v=3&s=ta&sd=DESC&cpl=2&bc=true&nw=1&pam=1&pm=1&set=1&uc=7054723&dc=14111810&o1=3&op1=200,16711680&o2=3&op2=50,255&o3=1&o4=89&op4=40,1,10536676&cf=(h%3E%3D(wh520.75)),(cu%3E%3D(wl521.3))